Induced pluripotent stem cells: Progress and future perspectives in the stem cell world

Cellular Reprogramming

Volumn 14, Issue 6, 2012, Pages 459-470

  Rezanejad, Habib ^a   Matin, Maryam M ^a  

^a FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; AROMATIC LEVO AMINO ACID DECARBOXYLASE; ECAT1 PROTEIN; ESG1 PROTEIN; FBX15 PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 2; KRUPPEL LIKE FACTOR 4; LENTIVIRUS VECTOR; LIN28 PROTEIN; MYC PROTEIN; NUCLEIC ACID; PROTEIN; RETROVIRUS VECTOR; STAGE SPECIFIC EMBRYO ANTIGEN 1; STAT3 PROTEIN; TCL1 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; EPIGENETICS; GENE EXPRESSION; GENE VECTOR; HEMOPHILIA A; HUMAN; INNER CELL MASS; NONHUMAN; NUCLEAR REPROGRAMMING; OOCYTE; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; SICKLE CELL ANEMIA; SOMATIC CELL; SOMATIC CELL NUCLEAR TRANSFER; STEM CELL TRANSPLANTATION; TRANSGENE; TRANSIENT EXPRESSION; TRANSIENT TRANSFECTION;

ANIMALS; CELL DIFFERENTIATION; CELL FUSION; DRUG DISCOVERY; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NUCLEAR TRANSFER TECHNIQUES; REGENERATIVE MEDICINE; TISSUE THERAPY;

EID: 84870537575     PISSN: 21524971     EISSN: 21524998     Source Type: Journal    
DOI: 10.1089/cell.2012.0039     Document Type: Article

References (155)

1. Abdel-Salam, O.M. (2011). Stem cell therapy for Alzheimer's disease. CNS Neurol. Disord. Drug Targets. 10, 459-485.
2. Anokye-Danso, F., Trivedi, C.M., Juhr, D., et al. (2011). Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 8, 376-388.
3. Aoi, T., Yae, K., Nakagawa, M., et al. (2008). Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321, 699-702.
4. Aoki, T., Ohnishi, H., Oda, Y., et al. (2010). Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC. Tissue Eng. Part A. 16, 2197-2206.
5. Avilion, A., Nicolis, S., Pevny, L., et al. (2003). Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 17, 126-140.
6. Balzer, E., and Moss, E.G. (2007). Localization of the developmental timing regulator Lin28 to mRNP complexes, P-bodies and stress granules. RNA Biol. 4, 16-25.
7. Ban, H., Nishishita, N., Fusaki, N., et al. (2011). Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc. Natl. Acad. Sci. USA 108, 14234-14239.
8. Boland, M.J., Hazen, J.L., Nazor, K.L., et al. (2009). Adult mice generated from induced pluripotent stem cells. Nature 461, 91-94.
9. Boyer, L., Lee, T., Cole, M., et al. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947-956.
10. Boyer, L.A., Plath, K., Zeitlinger, J., et al. (2006). Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441, 349-353.
11. Brambrink, T., Foreman, R., Welstead, G.G., et al. (2008). Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2, 151-159.
12. Briggs, R., and King, T.J. (1952). Transplantation of living nuclei from blastula cells into enucleated frogs' eggs. Proc. Natl. Acad. Sci. USA 38, 455-463.
13. Brinster, R.L. (1974). The effect of cells transferred into the mouse blastocyst on subsequent development. J. Exp. Med. 140, 1049-1056.
14. Bussmann, L.H., Schubert, A., Vu Manh, T.P., et al. (2009). A robust and highly efficient immune cell reprogramming system. Cell Stem Cell 5, 554-566.
15. Carey, B.W., Markoulaki, S., Hanna, J., et al. (2009). Repro-gramming of murine and human somatic cells using a single polycistronic vector. Proc. Natl. Acad. Sci. USA 106, 157-162.
16. Cho, H.J., Lee, C.S., Kwon, Y.W., et al. (2010). Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation. Blood 116, 386-395.
17. Chen, X., Xu, H., Yuan, P., et al. (2008). Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133, 1106-1117.
18. Chun, Y.S., Chaudhari, P., and Jang, Y.Y. (2010). Applications of patient-specific induced pluripotent stem cells; focused on disease modeling, drug screening and therapeutic potentials for liver disease. Int. J. Biol. Sci. 6, 796-805.
19. Cui, C., Rao, L.J., Cheng, L.Z., et al. (2009). Generation and application of human iPS cells. Chin. Sci. Bull. 54, 9-13.
20. Davis, R.L.,Weintraub, H., and Lassar, A.B. (1987). Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51, 987-1000.
21. Deng, J., Shoemaker, R., Xie, B., et al. (2009). Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat. Biotechnol. 27, 353-360.
22. Desponts, C., and Ding, S. (2010). Using small molecules to improve generation of induced pluripotent stem cells from somatic cells. Methods Mol. Biol. 636, 207-218.
23. Dimos, J.T., Rodolfa, K.T., Niakan, K.K., et al. (2008). Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218-1221.
24. Ebert, A.D., Yu, J., Rose, F.F., Jr., et al. (2009). Induced pluripo-tent stem cells from a spinal muscular atrophy patient. Nature. 457, 277-280.
25. Eminli, S., Utikal, J., Arnold, K., et al. (2008). Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells 26, 2467-2674.
26. Enver, T., Soneji, S., Joshi, C., et al. (2005). Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum. Mol. Genet. 14, 3129-3140.
27. Esteban, M.A., Xu, J., Yang, J., et al. (2009). Generation of induced pluripotent stem cell lines from Tibetan miniature pig. J. Biol. Chem. 284, 17634-17640.
28. Evans, M.J., and Kaufman, M.H. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156.
29. Faradonbeh, M.Z., Gharechahi, J., Mollamohammadi, S., et al. (2012). An orthogonal comparison of the proteome of human embryonic stem cells with that of human induced pluripotent stem cells of different genetic background. Mol. Biosyst. 8, 1833-1840.
30. Feng, Q., Lu, S.J., Klimanskaya, I., et al. (2010). Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 28, 704-712.
31. Foshay, K.M., Looney, T.J., Chari, S., et al. (2012). Embryonic stem cells induce pluripotency in somatic cell fusion through biphasic reprogramming. Mol. Cell 46, 159-170.
32. Fusaki, N., Ban, H., Nishiyama, A., et al. (2009). Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 85, 348-362.
33. Galende, E., Karakikes, I., Edelmann, L., et al. (2010). Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells. Cell. Reprogram. 12, 117-125.
34. Gaspar-Maia, A., Alajem, A., Polesso, F., et al. (2009). Chd1 regulates open chromatin and pluripotency of embryonic stem cells. Nature 460, 863-868.
35. Giorgetti, A., Montserrat, N., Aasen, T., et al. (2009). Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 5, 353-357.
36. Guo, G., Yang, J., Nichols, J., et al. (2009). Klf4 reverts devel-opmentally programmed restriction of ground state plur-ipotency. Development. 136, 1063-1069.
37. Gurdon, J.B. (1962). The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J. Em-bryol. Exp. Morphol. 10, 622-640.
38. Gurdon, J.B., Laskey, R.A., and Reeves, O.R. (1975). The developmental capacity of nuclei transplanted from keratinized skin cells of adult frogs. J. Embryol. Exp. Morphol. 34, 93-112.
39. Gurdon, J.B., Byrne, J.A., and Simonsson, S. (2003). Nuclear re-programming and stem cell creation. Proc. Natl. Acad. Sci. USA 100, 11819-11822.
40. Hamilton, B., Feng, Q., Ye, M., et al. (2009). Generation of induced pluripotent stem cells by reprogramming mouse embryonic fibroblasts with a four transcription factor, doxycycline inducible lentiviral transduction system. J. Vis. Exp. 33, 1447.
41. Han, X., Han, J., Ding, F., et al. (2011). Generation of induced pluripotent stem cells from bovine embryonic fibroblast cells. Cell Res. 21, 1509-1512.
42. Hanna, J., Wernig, M., Markoulaki, S., et al. (2007). Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318, 1920-1923.
43. Hochedlinger, K., and Jaenisch, R. (2002). Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature 415, 1035-1038.
44. Huangfu, D., Maehr, R., Guo, W., et al. (2008a). Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol. 26, 795-797.
45. Huangfu, D., Osafune, K., Maehr, R., et al. (2008b). Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol. 26, 1269-1275.
46. Hussein, S.M., Batada, N.N., Vuoristo, S., et al. (2011). Copy number variation and selection during reprogramming to pluripotency. Nature 471, 58-62.
47. Inoue, K., Wakao, H., Ogonuki, N., et al. (2005). Generation of cloned mice by direct nuclear transfer from natural killer T cells. Curr. Biol. 15, 1114-1148.
48. Jaenisch, R., and Young, R. (2008). Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132, 567-582.
49. Jia, F., Wilson, K.D., Sun, N., et al. (2010). A nonviral minicircle vector for deriving human iPS cells. Nat. Methods 7, 197-199.
50. Kaji, K., Norrby, K., Paca, A., et al. (2009). Virus free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458, 771-775.
51. Kanakura, P., McLean, C., Sheppard, A., et al. (2005). LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent. Development 132, 885-896.
52. Kelly, S.J. (1977). Studies of the developmental potential of 4-and 8-cell stage mouse blastomeres. J.Exp. Zool. 200, 365-376.
53. Kim, J., Chu, J., Shen, X., et al. (2008). An extended transcrip-tional network for pluripotency of embryonic stem cells. Cell 132, 1049-1061.
54. Kim, D., Kim, C.H., Moon, J.I., et al. (2009a). Generation of human induced pluripotent stem cells by direct delivery of re-programming proteins. Cell Stem Cell 4, 472-476.
55. Kim, J.B., Greber, B., Arauzo-Bravo, M.J., et al. (2009b). Direct reprogramming of human neural stem cells by OCT4. Nature 461, 649-653.
56. Kim, K., Doi, A., Wen, B., et al. (2010). Epigenetic memory in induced pluripotent stem cells. Nature 467, 285-290.
57. Kleinsmith, L.J., and Pierce, G.B.Jr. (1964). Multipotentiality of single embryonal carcinoma cells. Cancer Res. 24, 1544-1551.
58. Knoepfler, P.S., Zhang, X.Y., Cheng, P.F., et al. (2006). Myc influences global chromatin structure. EMBO J. 25, 2723-2734.
59. Kondo, M., Scherer, D.C., Miyamoto, T., et al. (2000). Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature 407, 383-386.
60. Laurent, L.C., Ulitsky, I., Slavin, I., et al. (2011). Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogram-ming and time in culture. Cell Stem Cell 8, 106-118.
61. Lee, G., Papapetrou, E.P., Kim, H., et al. (2009). Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461, 402-406.
62. Li, W., Wei, W., Zhu, S., et al. (2009). Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 4, 16-19.
63. Li, Y., Cang, M., Lee, A.S., et al. (2011). Reprogramming of sheep fibroblasts into pluripotency under a drug-inducible expression of mouse-derived defined factors. PLoS One 6, e15947.
64. Li, Y., McClintick, J., Zhong, L., et al. (2005). Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood 105, 635-637.
65. Lin, T., Ambasudhan, R., Yuan, X., et al. (2009). A chemical platform for improved induction of human iPSCs. Nat. Methods. 6, 805-808.
66. Liu, J., Balehosur, D., Murray, B., et al. (2012). Generation and characterization of reprogrammed sheep induced pluripotent stem cells. Theriogenology 77, 338-346.
67. Liu, H., Zhu, F., Yong, J., et al. (2008). Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell 3, 587-590.
68. Ma, D., Wei, H., Lu, J., et al. (2012). Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardio-myopathy. Eur Heart J. doi: 10.1093/eurheartj/ehs226.
69. Macarthur, C.C., Fontes, A., Ravinder, N., et al. (2012). Generation of human-induced pluripotent stem cells by a nonintegrating RNA Sendai virus vector in feeder-free or xeno-free conditions. Stem Cells Int. doi: 10.1155/2012/564612.
70. Maherali, N., Sridharan, R., Xie, W., et al. (2007). Directly re-programmed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1, 55-70.
71. Maherali, N., Ahfeldt, T., Rigamonti, A., et al. (2008). A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 3, 340-345.
72. Markoulaki, S., Hanna, J., Beard, C., et al. (2009). Transgenic mice with defined combinations of drug-inducible repro-gramming factors. Nat Biotechnol 27, 169-171.
73. Martin, G.R. (1981). Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 78, 7634-7638.
74. Masui, S., Nakatake, Y., Toyooka, Y., et al. (2007). Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse. Nat. Cell Biol. 9, 625-635.
75. Matin, M.M., Walsh, J.R., Gokhale, P., et al. (2004). Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference. Stem Cells 22, 659-668.
76. Matsui, Y., Zsebo, K., and Hogan, B.L.M. (1992). Derivation of pluripotential embryonic stem-cells from murine primordial germ-cells in culture. Cell 70, 841-847.
77. Meissner, A., Wernig, M., and Jaenisch, R. (2007). Direct repro-gramming of genetically unmodified fibroblasts into pluripo-tent stem cells. Nat. Biotechnol. 25, 1177-1181.
78. Mikkelsen, T.S., Hanna, J., Zhang, X., et al. (2008). Dissecting direct reprogramming through integrative genomic analysis. Nature 3, 49-55.
79. Miller, R.A., and Ruddle, F.H. (1976). Pluripotent teratocarci-noma- thymus somatic cell hybrids. Cell 9, 45-55.
80. Miller, R.A., and Ruddle, F.H. (1977). Teratocarcinoma X friend erythroleukemia cell hybrids resemble their pluripotent embryonal carcinoma parent. Dev. Biol. 56, 157-173.
81. Mitsui, K., Tokuzawa, Y., Itoh, H., et al. (2003). The homeo-protein Nanog is required for maintenance of pluripotency in mouse. Cell 113, 631-642.
82. Miura, K., Okada, Y., Aoi, T., et al. (2009). Variation in the safety of induced pluripotent stem cell lines. Nat. Biotechnol. 27, 743-745.
83. Montserrat, N., de Onate, L., Garreta, E., et al. (2012). Generation of feeder free pig induced pluripotent stem cells without Pou5f1. Cell Transplant 21, 815-825.
84. Muller, F.J., Laurent, L.C., Kostka, D., et al. (2008). Regulatory networks define phenotypic classes of human stem cell lines. Nature 455, 401-405.
85. Muller, L.U.W., Daley, G.Q., and Williams, D.A. (2009). Upping the ante: Recent advances in direct reprogramming. Mol. Ther. 17, 947-953.
86. Nagy, K., Sung, H.K., Zhang, P., et al. (2011). Induced pluripo-tent stem cell lines derived from equine fibroblasts. Stem Cell Rev. 7, 693-702.
87. Nakagawa, M., Koyanagi, M., Tanabe, K., et al. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26, 101-106.
88. Nakhaei-Rad, S., Bahrami, A.R., Mirahmadi, M., et al. (2012). New windows to enhance direct reprogramming of somatic cells towards induced pluripotent stem cells. Biochem. Cell Biol. 90, 115-123.
89. Neshati, Z., Matin, M.M., Bahrami, A.R., et al. (2010). Differentiation of mesenchymal stem cells to insulin-producing cells and their impact on type 1 diabetic rats. J. Physiol. Biochem. 66, 181-187.
90. Nishishita, N., Shikamura, M., Takenaka, C., et al. (2012). Generation of virus-free induced pluripotent stem cell clones on a synthetic matrix via a single cell subcloning in the näive state. PLoS One 7, e38389.
91. Niwa, H., Miyazaki, J., and Smith, A. (2000). Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24, 372-376.
92. Okita, K., Ichisaka, T., and Yamanaka, S. (2007). Generation of germline-competent induced pluripotent stem cells. Nature 448, 313-317.
93. Okita, K., Nakagawa, M., Hyenjong, H., et al. (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science 322, 949-953.
94. Okita, K.,Nagata, N., and Yamanaka, S. (2011). Immunogenicity of induced pluripotent stem cells. Circ. Res. 109, 720-721.
95. Patel, M., and Yang, S. (2010). Advances in reprogramming somatic cells to induced pluripotent stem cells. Stem Cell Rev. 6, 367-380.
96. Park, I., Arora, N., Huo, H., et al. (2008). Disease-specific induced pluripotent stem cells. Cell 134, 877-886.
97. Pick, M., Stelzer, Y., Bar-Nur, O., et al. (2009). Clone and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells. 27, 2686-2690.
98. Polesskaya, A., Cuvellier, S., Naguibneva, I., et al. (2007). Lin-28 binds IGF-2 mRNA and participates in skeletal myo-genesis by increasing translation efficiency. Genes Dev. 21, 1125-1138.
99. Qin, D., Li, W., and Zhang, J. (2007). Direct generation of ES-like cells from unmodified mouse embryonic fibroblasts by Oct4/Sox2/Myc/Klf4. Cell Res. 17, 959-962.
100. Rassouli, F.B., and Matin, M.M. (2009). Gene silencing in human embryonic stem cells by RNA interference. Biochem. Biophys. Res. Commun. 390, 1106-1110.
101. Raya, A., Rodriguez-Piza, I., Guenechea, G., et al. (2009). Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460, 53-59.
102. Ren, J., Pak, Y., He, L., et al. (2011). Generation of hircine-in-duced pluripotent stem cells by somatic cell reprogramming. Cell Res. 21, 849-853.
103. Richards, M., Fong, C.Y., Chan, W.K., et al. (2002). Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat. Biotechnol. 20, 933-936.
104. Richards, M., Tan, S.P., Tan, J.H., et al. (2004). The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells 22, 51-64.
105. Rideout, W., Hochedlinger, K., Kyba, M., et al. (2002). Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 109, 17-27.
106. Rodda, D., Chew, J., Lim, L., et al. (2005). Transcriptional regulation of Nanog by OCT4 and SOX2. J. Biol. Chem. 280, 24731-24737.
107. Shi, Y., Do, J.T., Desponts, C., et al. (2008). A combined chemical and genetic approach for the generation of induced pluripo-tent stem cells. Cell Stem Cell 2, 525-528.
108. Shuang, L., and EnKui, D. (2008). Advances in the study on induced pluripotent stem cells. Chin. Sci. Bull. 53, 709-717.
109. Silva, J., Barrandon, O., Nichols, J., et al. (2008). Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol. 6, e253.
110. Singhal, N., Graumann, J., Wu, G., et al. (2010). Chromatin-remodeling components of the BAF complex facilitate repro-gramming. Cell 141, 943-955.
111. Soldner, F., Hockemeyer, D., Beard, C., et al. (2009). Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136, 964-977.
112. Spivakov, M., and Fisher, A.G. (2007). Epigenetic signatures of stem-cell identity. Nat. Rev. Genet. 8, 263-271.
113. Sridharan, R., Tchieu, J., Mason, M.J., et al. (2009). Role of the murine reprogramming factors in the induction of plur-ipotency. Cell 136, 364-377.
114. Stadtfeld, M., and Hochedlinger, K. (2009). Without a trace? PiggyBac-ing toward pluripotency. Nat. Methods 6, 329-330.
115. Stadtfeld, M., and Hochedlinger, K. (2010). Induced plur-ipotency: History, mechanisms, and applications. Genes Dev. 24, 2239-2263.
116. Stadtfeld, M., Brennand, K., and Hochedlinger, K. (2008a). Re-programming of pancreatic beta cells into induced pluripotent stem cells. Curr. Biol. 18, 890-894.
117. Stadtfeld, M., Nagaya, M., Utikal, J., et al. (2008b). Induced pluripotent stem cells generated without viral integration. Science 322, 945-949.
118. Stadtfeld, M., Maherali, N., Borkent, M., et al. (2010). A reprogrammable mouse strain from gene-targeted embryonic stem cells. Nat. Methods 7, 53-55.
119. Stewart, T.A., and Mintz, B. (1982). Recurrent germ-line transmission of the teratocarcinoma genome from the METT-1 culture line to progeny in vivo. J. Exp. Zool. 224, 465-469.
120. Sun, N., Longaker, M.T., and Wu, J.C. (2010). Human iPS cell-based therapy: considerations before clinical applications. Cell Cycle 9, 880-885.
121. Swistowski, A., Peng, J., Liu, Q., et al. (2010). Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells 28, 1893-1904.
122. Tada, M., Takahama, Y., Abe, K., et al. (2001). Nuclear repro-gramming of somatic cells by in vitro hybridization with ES cells. Curr. Biol. 11, 1553-1558.
123. Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676.
124. Takahashi, K., Tanabe, K., Ohnuki, M., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 1-12.
125. Takeda, J., Seino, S., and Bell, G.I. (1992). Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues. Nucleic Acids Res. 20, 4613-4620.
126. Tang, Y., Lin, C.J., and Tian, X.C. (2011). Functionality and transduction condition evaluation of recombinant Klf4 for improved reprogramming of iPS cells. Cell. Reprogram. 13, 99-112.
127. Taranger, C.K., Noer, A., Sorensen, A.L., et al. (2005). Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Mol. Biol. Cell 16, 5719-5935.
128. Tat, P.A., Sumer, H., Jones, K.L., et al. (2010). The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells. Cell Transplant. 19, 525-536.
129. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147.
130. Unger, C., Felldin, U., Nordenskjold, A., et al. (2008). Derivation of human skin fibroblast lines for feeder cells of human embryonic stem cells. Curr. Protoc. Stem Cell Biol. Chapter 1, Unit 1C 7.
131. Utikal, J., Maherali, N., Kulalert, W., et al. (2009). Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J. Cell Sci. 122, 3502-3510.
132. van der Heyden, M.A., and Jonsson, M.K. (2012). Personalized medicine and the role of induced pluripotent stem cells. Car-diovasc. Res. doi: 10.1093/cvr/cvs242.
133. Wakayama, T., and Yanagimachi, R. (1999). Cloning of male mice from adult tail-tip cells. Nat. Genet. 22, 127-128.
134. Wang, H., Fang, H., Dai, J., et al. (2012). Induced pluripotent stem cells for spinal cord injury therapy: current status and perspective. Neurol Sci. doi: 10.1007/s10072-012-1145-3.
135. Warren, L., Manos, P.D., Ahfeldt, T., et al. (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618-630.
136. Wernig, M., Meissner, A., Foreman, R., et al. (2007). In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448, 318-324.
137. Wernig, M., Zhao, J., Pruszak, J., et al. (2008). Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. USA 105, 5856-5861.
138. Wilmut, I., Schnieke, A.E., McWhir, J., et al. (1997). Viable offspring derived from fetal and adult mammalian cells. Nature 385, 810-813.
139. Wilson, K.D., Venkatasubrahmanyam, S., Jia, F., et al. (2009). MicroRNA profiling of human-induced pluripotent stem cells. Stem Cells Dev. 18, 749-758.
140. Woltjen, K., Michael, I.P., Mohseni, P., et al. (2009). piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458, 766-770.
141. Wu, Y., Zhang, Y., Mishra, A., et al. (2010). Generation of induced pluripotent stem cells from newborn marmoset skin fibroblasts. Stem Cell Res. 4, 180-188.
142. Xie, H., Ye, M., Feng, R., et al. (2004). Stepwise reprogramming of B cells into macrophages. Cell 117, 663-676.
143. Xu, D., Alipio, Z., Fink, L.M., et al. (2009). Phenotypic correction of murine hemophilia A using an iPS cell-based therapy. Proc. Natl. Acad. Sci. USA 106, 808-813.
144. Yamanaka, S. (2007). Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1, 39-49.
145. Yamanaka, S. (2009). A fresh look at iPS cells. Cell 137, 13-17.
146. Ye, L., Chang, J.C., Lin, C., et al. (2009). Induced pluripo-tent stem cells offer new approach to therapy in thalas-semia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc. Natl. Acad. Sci. USA 106, 9826-9830.
147. Yi, F., Qu, J., Li, M., et al. (2012). Establishment of hepatic and neural differentiation platforms of Wilson's disease specific induced pluripotent stem cells. Protein Cell doi: 10.1007/s13238-012-2064-z.
148. Yu, J., Vodyanik, M.A., Smuga-Otto, K., et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920.
149. Yukawa, H., Noguchi, H., Nakase, I., et al. (2010). Transduction of cell-penetrating peptides into induced pluripotent stem cells. Cell Transplant. 19, 901-909.
150. Yusa, K., Rad, R., Takeda, J., et al. (2009). Generation of trans-gene-free induced pluripotent mouse stem cells by the pig-gyBac transposon. Nat. Methods 6, 363-369.
151. Zaehres, H., and Scholer, H. (2007). Induction of pluripotency: From mouse to human. Cell 131, 834-835.
152. Zhao, T., Zhang, Z.N., Rong, Z., et al. (2011). Immunogenicity of induced pluripotent stem cells. Nature 474, 212-215.
153. Zhou, H., Wu, S., Joo, J.Y., et al. (2009). Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4, 381-384.
154. Zhou, W., and Freed, C.R. (2009). Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 27, 2667-2674.
155. Zwi, L., Caspi, O., Arbel, G., et al. (2009). Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 120, 1513-1523.